Charles W. Newhall III, Director at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 2,500 shares at $28.01 ($70K) on 2023-11-16, disclosed to the SEC on 2023-11-20.
Open-market sale of $70k SUPN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SUPN | SELL | 2025-08-27 | $45K | — | Filing → |
| SUPN | SELL | 2025-08-26 | $64K | — | Filing → |
| SUPN | SELL | 2024-11-12 | $388K | — | Filing → |